Document Detail

Primary cutaneous mucormycosis caused by Rhizomucor variabilis in an immunocompetent patient.
MedLine Citation:
PMID:  19562506     Owner:  NLM     Status:  MEDLINE    
Primary cutaneous mucormycosis is an uncommon disease and occurs mainly in patients with immunocompromised disorders. We report a case of cutaneous mucormycosis in an immunocompetent man in whom no definite precipitating factors were noted. The isolate was identified as Rhizomucor variabilis according to the fungus morphology and DNA sequencing results. The lesion was successfully treated with oral Itraconazole, although the in vitro drug-susceptibility test showed resistance.
Ying Zhao; Qiangqiang Zhang; Li Li; Junhao Zhu; Kefei Kang; Lianjun Chen
Related Documents :
19095216 - Collagen in the transversalis fascia of patients with indirect inguinal hernia: a case-...
2535016 - Drug eruptions (a series of 148 cases).
20202926 - Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis em...
8389536 - Primary and secondary erythema migrans in central wisconsin.
21661416 - Double-balloon enteroscopy in the diagnosis and management of small-bowel diseases.
832786 - Studies of the duodenal and fecal flora in gastrointestinal disorders during treatment ...
Publication Detail:
Type:  Case Reports; Journal Article     Date:  2009-06-27
Journal Detail:
Title:  Mycopathologia     Volume:  168     ISSN:  1573-0832     ISO Abbreviation:  Mycopathologia     Publication Date:  2009 Nov 
Date Detail:
Created Date:  2009-10-13     Completed Date:  2009-12-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7505689     Medline TA:  Mycopathologia     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  243-7     Citation Subset:  IM    
Department of Dermatology, Huashan Hospital, Fudan University, 200040, Shanghai, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antifungal Agents / therapeutic use
Itraconazole / therapeutic use
Middle Aged
Mucormycosis / drug therapy,  microbiology*
Rhizomucor / physiology*
Reg. No./Substance:
0/Antifungal Agents; 84625-61-6/Itraconazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Long-term neurodevelopmental effects of early detection and treatment in a 6-year-old patient with a...
Next Document:  Molecular cloning, sequence and expression analysis of ZmArf2, a maize ADP-ribosylation factor.